Journals / Erciyes Tıp Dergisi / 2007 / Cilt: 29 - Sayı: 5

Donohue's syndrome (leprechaunism)

Donohue sendromu (leprechaunısm)

Pages
415–418
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Key Words: Leprechaunism, hypertrichosis, newborn.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Donohue's syndrome or leprechaunism is characterized by prenatal onset growth retardation, lacking subcutaneous fat and decreased muscle mass, insulin resistance and other phenotypic and hormonal changes.
📊
Key Findings & Data:Metabolic characteristics of the disease include postprandial hyperglycemia, fasting hypoglycemia, insulin resistance, hyperinsulinemia, and failure to thrive.
💡
Conclusion & Impact:Key Words: Leprechaunism, hypertrichosis, newborn.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Donohue's syndrome or leprechaunism is characterized by prenatal onset growth retardation, lacking subcutaneous fat and decreased muscle mass, insulin resistance and other phenotypic and hormonal changes. Metabolic characteristics of the disease include postprandial hyperglycemia, fasting hypoglycemia, insulin resistance, hyperinsulinemia, and failure to thrive. Most of the cases have severe insulin resistance with the mutation of the insulin receptor gene.The physical features most often associated with this condition including hypertrichosis, pachyderma, acanthosis nigricans, prominent genitalia, and elfin-like facial characteristics of prominent eyes, wide nostrils, thick lips, and large, low-set ears. Key Words: Leprechaunism, hypertrichosis, newborn.

Özet

Donohue sendromu prenatal dönemde baslayan büyüme geriliği, tipik yüz görünümü, cilt altı yağ dokusu ve kas dokusunda azalma ve insülin direnci ile karakterize otozomal resesif geçişli bir hastalıktır. Birçok fenotipik özellikler yanında değişik hormonal anormallikler de bildirilmiştir. Hastaliğin tipik metabolik bulguları postprandiyal hiperglisemi, preprandiyal hipoglisemi, insülin direnci, hiperinsulinemi ve büyüme geriliği olarak gözlenmektedir. Bu klinik duruma en sık eslik eden fizik bulgular akantozis nigrikans, klitoris hipertrofisi ve "elfin face" yüz görünümüdür. Bu yüz görünümü belirgin canlı bakan gözler, hipertelorizm, geniş ve antevert burun delikleri, kalın dudaklar, büyük, deforme ve düşük kulaklar şeklindedir.

🔖

Cite This Article

CANPOLAT, M., BÜYÜKKAYHAN, D., AKCAKUŞ, M., GÜNEŞ, T., KÖKLÜ, E., KURTOĞLU, S., ÖZTÜRK, M. (2022). Donohue's syndrome (leprechaunism). Erciyes Tıp Dergisi, Cilt: 29 - Sayı: 5, 415–418. https://ajindex.com/articles/502713

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Donohue WL. Clinicopathologic conference at the hospital for sick children dysendocrinism. J Pediatr 1948; 32:739-48
  2. Moller D, Rahilly S. Leprechaunism. In: Moller D(ed), Insulin Resistance. Published by Willey. 1993 p 59-61
  3. Donohue WL,Uchida I. Leprechaunism. J Pediatr 1954;45:505-519
  4. Rosenberg AM, Haworth JC, Degroot GW, Trevenen CL, Rechler MM. A Case of leprechaunism with severe hyperinsulinemia. Am J Dis Child 1980; 134:170-175
  5. Roth SI, Schedewie HK, Herzberg VK, Olefsky J, Elders MJ, Rubenstein A. Cutaneous manifestations of leprechaunism. Arch Dermatol 1981;117:531-535
  6. Geffner ME, Golde DW. Selective insulin action on skin ovary and heart in insulin resistant states. Diabetes Care 1988; 11: 500-505
  7. D'ercole Al, Underwood LE, Groelke J, Plet A. Leprechaunism. Studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation. J Clin Endocrinol Metab 1979; 48: 495-502
  8. Van der Vorm ER, Kuipers A, Kielkopf- Renner S, Krans HM, Moller W, Maassen JA. A mutation in the insulin receptor that impirs proreceptor processing but not insulin binding J Biol Chem 1994; 269: 14297-14302 9. Loan D, Dimitriu L, Belengeanu V, BistriceanuM, Maximilian C. Leprechaunism: report of two cases and review. Endocrinologie 1988; 26:205-209
  9. Tokatli A, Ozsoylu S, Ozme S. Leprechaunism (Donohue's syndrome): a case report. Turk J Pediatr. 1993; 35(4): 319-322. 11-Nakae J, Kato M, Murashita M, Shinohara N, Tajima T, Fujieda K. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.J Clin Endocrinol Metab 1998; 83: 542-549
  10. Duran Arslan, Selim Kurtoğlu, Mustafa Kendirci, Ahmet Çiftçi. Leprechaunism: Olgu Sunumu. Erciyes Tip Dergisi 1995; 17: 67-70.